1. Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
- Author
-
Jadlowsky, Julie K., Hexner, Elizabeth O., Marshall, Amy, Grupp, Stephan A., Frey, Noelle V., Riley, James L., Veloso, Elizabeth, McConville, Holly, Rogal, Walter, Czuczman, Cory, Hwang, Wei-Ting, Li, Yimei, Leskowitz, Rachel M., Farrelly, Olivia, Karar, Jayashree, Christensen, Shannon, Barber-Rotenberg, Julie, Gaymon, Avery, Aronson, Naomi, Bernstein, Wendy, Melenhorst, Jan Joseph, Roche, Aoife M., Everett, John K., Zolnoski, Sonja A., McFarland, Alexander G., Reddy, Shantan, Petrichenko, Angelina, Cook, Emma J., Lee, Carole, Gonzalez, Vanessa E., Alexander, Kathleen, Kulikovskaya, Irina, Ramírez-Fernández, Ángel, Minehart, Janna C., Ruella, Marco, Gill, Saar I., Schuster, Stephen J., Cohen, Adam D., Garfall, Alfred L., Shah, Payal D., Porter, David L., Maude, Shannon L., Levine, Bruce L., Siegel, Donald L., Chew, Anne, McKenna, Stephen, Lledo, Lester, Davis, Megan M., Plesa, Gabriela, Herbst, Friederike, Stadtmauer, Edward A., Tebas, Pablo, DiNofia, Amanda, Haas, Andrew, Haas, Naomi B., Myers, Regina, O’Rourke, Donald M., Svoboda, Jakub, Tanyi, Janos L., Aplenc, Richard, Jacobson, Jeffrey M., Ko, Andrew H., Cohen, Roger B., June, Carl H., Bushman, Frederic D., and Fraietta, Joseph A.
- Published
- 2025
- Full Text
- View/download PDF